Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...
Walking pneumonia cases in the United States, especially among children, are on the rise and have been since early spring, according to the Centers for Disease Control and Prevention. Infections ...